Pyrazole Ester Route for Scalable Chiral Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide is inefficient due to poor solubility of intermediates, leading to difficult chiral separation and formation of side products, making large-scale production challenging.
Innovation Solution
A novel synthesis process involving the use of bromo-pyridine and iodo-pyridine intermediates, along with a pyrazole ester intermediate, allows for scalable production by optimizing solubility and introducing new synthetic steps for conversion, including iridium-catalyzed borylation and halogenation/halogen dance protocols.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the known synthesis route using intermediate (XV) is used, then the target compound can be produced, but the poor solubility of intermediate (XV) in organic solvents makes chiral separation difficult and requires expensive supercritical fluid chromatography
Solution Approach 1:
The patent changes the chemical structure parameter of the intermediate from amide (XV) to ester (VI), which fundamentally alters the solubility characteristics. The ester intermediate (VI) exhibits significantly improved solubility in organic solvents compared to the amide intermediate (XV), enabling effective chiral separation by conventional chromatography methods and eliminating the need for expensive supercritical fluid chromatography.
2Manufacturing precision
If the known synthesis route is used, then the target compound can be obtained, but side products are formed during conversion which complicates production of pure final product
Solution Approach 1:
The patent performs chiral separation at the ester intermediate stage (VI) before the coupling reaction that generates side products. By separating the enantiomers of the ester intermediate (VI) prior to reaction with the pyridine derivative, the subsequent synthesis proceeds from a single enantiomer, preventing the formation of diastereomeric side products and simplifying purification of the final product.
3Productivity
If the known synthesis route is used, then the target compound can be produced, but the process is not suitable for large-scale production due to multiple difficulties
Solution Approach 1:
The patent changes the functional group parameter from amide to ester in the key intermediate, which simultaneously improves solubility, enables conventional chiral separation methods, and eliminates side product formation. This single parameter change simplifies the overall process and makes it suitable for large-scale production.
Solution Approach 2:
The patent replaces expensive supercritical fluid chromatography equipment and procedures with conventional chromatography methods that use standard organic solvents and equipment. This substitution significantly reduces capital investment and operational costs for chiral separation, making the process economically viable for large-scale production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new process enhances the solubility of intermediates, enabling efficient chiral separation and cost-effective large-scale production of the target compound.
Implementation Method 1
iridium-catalyzed borylation
Implementation Method 2
reacting the compound of Formula (XIII) in the presence of a trialkylamine, preferably triethylamine with a lithium salt, preferably lithium bromide, lithium chloride or lithium hydroxide to yield a compound of Formula (XIV)
Data Source
AI summary
The application relates to processes for the preparation of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl) amino]pyrazole-4-carboxamide (I) which include (i) a synthesis for bromo and iodo pyridine intermediates, (ii) a synthesis of a pyrazole ester intermediate which can be obtained in enantiopure form and (iii) the combination of these intermediates into compound (I).